Abstract
Background Major depressive disorder (MDD) and chronic pain are highly comorbid and bidirectionally related, such that MDD typically interferes with chronic pain treatment and vice versa. Repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (DLPFC) is effective in treating MDD, but additional research is needed to determine if chronic pain interferes with rTMS for MDD.
Method Participants were 124 veterans (Mage=49.1, SD=13.8) scheduled for 30 sessions of rTMS across six weeks at the Veterans Affairs San Diego Healthcare System. Depression severity was monitored weekly using the Patient Health Questionnaire-9. Having any pain diagnosis, low back pain, or migraine/headache were assessed by chart review. Latent basis models were used to estimate change and change-by-pain diagnosis in depression scores during rTMS treatment.
Results A total of 92 participants (74%) had a documented pain diagnosis, 58 (47%) had low back pain, and 32 (26%) had migraine/headache. Depression scores initially decreased (linear slope estimate=-2.04, SE=0.26, p<.0001), but the rate of decrease slowed over time (quadratic slope estimate=0.18, SE=0.04, p<.001). Having any pain diagnosis, low back pain, or migraine/headache did not significantly differentiate overall amount of change. However, individuals with headache/migraine showed greater initial improvement but then an even faster slowing in rate of decrease than those without headache/migraine.
Conclusions Having any pain diagnosis, low back pain, or headache/migraine did not significantly interfere with improvement in depression; however, headache/migraine affected the timing of change. These data contribute to the ongoing support of rTMS as a viable treatment option for comorbid populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee/IRB of VA Medical Center of san diego california (Veterinary Affairs) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Support: Dr. Herbert is supported by Veterans Affairs Rehabilitation Research and Development Service under Career Development Award 1IK2RX002807.
Disclosure statement: None of the authors have any conflicts of interest to disclose.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos